Literature DB >> 18587649

HIV-1-infected astrocytes and the microglial proteome.

Tong Wang1, Nan Gong, Jianuo Liu, Irena Kadiu, Stephanie D Kraft-Terry, Joshua D Schlautman, Pawel Ciborowski, David J Volsky, Howard E Gendelman.   

Abstract

The human immunodeficiency virus (HIV) invades the central nervous system early after viral exposure but causes progressive cognitive, behavior, and motor impairments years later with the onset of immune deficiency. Although in the brain, HIV preferentially replicates productively in cells of mononuclear phagocyte (MP; blood borne macrophage and microglia), astrocytes also can be infected, at low and variable frequency, particularly in patients with encephalitis. Among their many functions, astrocytes network with microglia to provide the first line of defense against microbial infection; however, very little is known about astrocytes' consequences on MP. Here, we addressed this question using co-culture systems of HIV-infected mouse astrocytes and microglia. Pseudotyped vesicular stomatis virus/HIV was used to circumvent the absence of viral receptors and ensure cell genotypic uniformity for studies of intercellular communication. The study demonstrated that infected astrocytes show modest changes in protein elements compared to uninfected cells. In contrast, infected astrocytes induce robust changes in the proteome of HIV-1-infected microglia. Accelerated cell death and redox proteins, among others, were produced in abundance. The observations confirmed the potential of astrocytes to influence the neuropathogenesis of HIV-1 infection by specifically altering the neurotoxic potential of infected microglia and regulating viral maturation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18587649      PMCID: PMC2579774          DOI: 10.1007/s11481-008-9110-x

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  105 in total

1.  Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry.

Authors:  K Takahashi; S L Wesselingh; D E Griffin; J C McArthur; R T Johnson; J D Glass
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

Review 2.  Involvement of PP2A in viral and cellular transformation.

Authors:  Jason D Arroyo; William C Hahn
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

3.  Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism.

Authors:  J M Strizki; A V Albright; H Sheng; M O'Connor; L Perrin; F González-Scarano
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 4.  Neuropsychiatric aspects of HIV infection.

Authors:  I P Everall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

Review 5.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

6.  Serine 15 phosphorylation of p53 directs its interaction with B56gamma and the tumor suppressor activity of B56gamma-specific protein phosphatase 2A.

Authors:  Geoffrey P Shouse; Xin Cai; Xuan Liu
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

Review 7.  Chemokine receptors in HIV-1 infection of the central nervous system.

Authors:  D Gabuzda; J He; A Ohagen; A V Vallat
Journal:  Semin Immunol       Date:  1998-06       Impact factor: 11.130

8.  The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes.

Authors:  Suman Jayadev; Bomy Yun; Huy Nguyen; Hideaki Yokoo; Richard S Morrison; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2007-10-20       Impact factor: 4.147

9.  Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo.

Authors:  J D Reeves; S Hibbitts; G Simmons; A McKnight; J M Azevedo-Pereira; J Moniz-Pereira; P R Clapham
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

10.  CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor.

Authors:  Ying Liu; Hao Liu; Byung Oh Kim; Vincent H Gattone; Jinliang Li; Avindra Nath; Janice Blum; Johnny J He
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more
  26 in total

1.  HIV-1 CNS in vitro infectivity models based on clinical CSF samples.

Authors:  Borja Mora-Peris; Alan Winston; Lucy Garvey; Laura J Else; Robin J Shattock; Carolina Herrera
Journal:  J Antimicrob Chemother       Date:  2015-10-15       Impact factor: 5.790

2.  Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

Authors:  Pawel Ciborowski
Journal:  Biomark Med       Date:  2009-12       Impact factor: 2.851

Review 3.  A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.

Authors:  Stephanie D Kraft-Terry; Shilpa J Buch; Howard S Fox; Howard E Gendelman
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 4.  Role of p53 in neurodegenerative diseases.

Authors:  J Robert Chang; Mohammad Ghafouri; Ruma Mukerjee; Asen Bagashev; Tinatin Chabrashvili; Bassel E Sawaya
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

Review 5.  Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes.

Authors:  Anusha Ande; Carole McArthur; Anil Kumar; Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2013-07-04       Impact factor: 4.481

6.  Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins.

Authors:  Lijun Zhang; Xiaofang Jia; Xiaojun Zhang; Jianjun Sun; Xia Peng; Tangkai Qi; Fang Ma; Lin Yin; Yamin Yao; Chao Qiu; Hongzhou Lu
Journal:  Proteome Sci       Date:  2010-03-12       Impact factor: 2.480

Review 7.  NanoART, neuroAIDS and CNS drug delivery.

Authors:  Ari Nowacek; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

8.  Endogenous HIV-1 Vpr-mediated apoptosis and proteome alteration of human T-cell leukemia virus-1 transformed C8166 cells.

Authors:  Fang He; Yaoying Zeng; Xiaoping Wu; Yuhua Ji; Xianhui He; Thomas Andrus; Tuofu Zhu; Tong Wang
Journal:  Apoptosis       Date:  2009-10       Impact factor: 4.677

9.  Disruption of microglia histone acetylation and protein pathways in mice exhibiting inflammation-associated depression-like symptoms.

Authors:  Sandra L Rodriguez-Zas; Cong Wu; Bruce R Southey; Jason C O'Connor; Scott E Nixon; Robmay Garcia; Cynthia Zavala; Marcus Lawson; Robert H McCusker; Elena V Romanova; Jonathan V Sweedler; Keith W Kelley; Robert Dantzer
Journal:  Psychoneuroendocrinology       Date:  2018-06-30       Impact factor: 4.905

Review 10.  HIV-1 neuroimmunity in the era of antiretroviral therapy.

Authors:  Stephanie D Kraft-Terry; Andrew R Stothert; Shilpa Buch; Howard E Gendelman
Journal:  Neurobiol Dis       Date:  2010-01-04       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.